Long-acting Injectable Antipsychotics (LAIs) Report

By www.reliablemarketinsights.com

Report Details

Report Name

Global Long-acting Injectable Antipsychotics (LAIs) Market Growth 2024-2030 Story

Pages

105

Price

$ 3660

Features

Long-acting Injectable Antipsychotics (LAIs) Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Otsuka Pharmaceutical|||CHEPLAPHARM Arzneimittel GmbH|||Alkermes Pharma Ireland Limited|||Essential Pharma|||Janssen Pharmaceuticals|||Indivior UK Limited|||Qilu Pharmaceutical|||Lvye Pharmaceutical            

Countries Covered

              Americas|||United States|||Canada|||Mexico|||Brazil|||APAC|||China|||Japan|||Korea|||Southeast Asia|||India|||Australia|||Europe|||Germany|||France|||UK|||Italy|||Russia|||Middle East & Africa|||Egypt|||South Africa|||Israel|||Turkey|||GCC Countries            

Regions Covered

              global            

Prices

Single User License:

$ 3660

Multi User License:

$ 5490

Enterprise/Corporate User License:

$ 7320